[Edaily Starin YUN GI BACK Reporter] Singer and actor Park Ji-hoon’s fan meeting in Shanghai, China, has been canceled. Park Ji-hoon (Photo: News1) His agency, YY Entertainment, announced in an official statement on the 5th, “The ‘2026 PARK JI HOON CHINA FANMEETING [RE:FLECT] IN SHANGHAI,’ which we had previously announced would be held in September, will not take place due to unavoidable circumstances.” They added, “We sincerely apologize for any confusion this may have caused to the fans who were looking forward to the Shanghai fan meeting,” and continued, “We ask for your kind understanding. We will do our best to return with an even better performance in the future.” Park Ji-hoon has been conducting his Asian fan concert tour “RE:FLECT,” which began in Tokyo last May and has since visited Seoul, Kuala Lumpur, Ho Chi Minh City and Hanoi, Hong Kong, Taipei, Bangkok, and Singapore. He is scheduled to meet local fans in Macau on the 8th and in Jakarta on the 29th. Along with the cancellation of the Shanghai fan meeting, there have also been changes to the Manila concert schedule. The original Manila concert has been rescheduled to take place at The Grand Hall within the Grand Lisboa Palace Resort in Macau. Park Ji-hoon has been meeting viewers and audiences one after another through the movie *The Man Who Lives with the King*, released last February, and the TVING Original *The Legend of the Mess Sergeant*, which premiered in May. In particular, *The Man Who Lives with the King* was a huge hit, drawing 16.91 million viewers and becoming this year’s top-grossing film.
Kim Chang-soo, former president of Chung-Ang University, has taken office as the 21st chairman of the Private School Teachers’ Pension Fund (PSTPF) and has officially begun his duties. Having inherite…
With the deadline for stricter environmental regulations in the European automotive market just two months away, domestic cybersecurity companies are stepping up their efforts. This is because, starti…
Dr. Pooja Dua of Olix Pharmaceuticals, Inc.’s U.S. subsidiary, Olix US (Photo courtesy of the Drug Information Association (DIA))
Olix Pharmaceuticals, Inc.(226950)announced the development progre…